Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates

scientific article

Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CID/CIT736
P932PMC publication ID4007111
P698PubMed publication ID24235265

P50authorDavid K. ShayQ38641565
Richard ZimmermanQ42658961
Edward A BelongiaQ59829972
Arnold S. MontoQ59829998
Mary Patricia NowalkQ63170708
Michael L JacksonQ88969073
Joshua G PetrieQ89457943
Mark G. ThompsonQ91141663
Lois LameratoQ96231796
Lisa A JacksonQ97556689
Charles R RinaldoQ102058793
Suzanne E OhmitQ104720751
Manjusha GaglaniQ106490274
Swathi N ThakerQ114338918
Lydia ClipperQ114338922
Jennifer K MeeceQ114338925
P2093author name stringPo-Yung Cheng
Juhee Song
Marcus Zervos
Sarah M Spencer
Pedro Piedra
P2860cites workEffectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communitiesQ28741469
I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in EuropeQ28742719
The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based studyQ30400700
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysisQ30408691
Influence of prior influenza vaccination on antibody and B-cell responsesQ33361605
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010Q34129986
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza seasonQ34294175
Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy populationQ35191251
Variable efficacy of repeated annual influenza vaccinationQ36705674
Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strainsQ36854011
What does self rated health measure? Results from the British Whitehall II and French Gazel cohort studiesQ36933716
Influenza vaccine effectiveness in the community and the householdQ36956943
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza virusesQ37397023
Multiple genotypes of influenza B virus circulated between 1979 and 2003.Q37596513
The test-negative design for estimating influenza vaccine effectivenessQ38427246
Moderate influenza vaccine effectiveness in Victoria, Australia, 2011.Q40027900
Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adultsQ41326434
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year periodQ45760959
Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarityQ46107360
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 seasonQ47843797
Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies.Q50637887
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.Q50801938
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011.Q51168887
Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination.Q53091538
Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza seasonQ56770384
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?Q80208528
Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protectionQ85094818
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectvaccineQ134808
influenza vaccineQ383260
P304page(s)319-327
P577publication date2013-11-13
P1433published inClinical Infectious DiseasesQ5133764
P1476titleInfluenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates
P478volume58

Reverse relations

cites work (P2860)
Q384101592014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
Q57452617A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates from Observational Studies
Q36991782A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season
Q90409521A Population-Based Propensity Score-Matched Study to Assess the Impact of Repeated Vaccination on Vaccine Effectiveness for Influenza-Associated Hospitalization Among the Elderly
Q61445511A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
Q36389642A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants
Q38692107A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children.
Q30396097Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains
Q38729900Application of an Individual-Based Transmission Hazard Model for Estimation of Influenza Vaccine Effectiveness in a Household Cohort
Q38864751Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness
Q98568367Assessment of indirect protection from maternal influenza immunization among non-vaccinated household family members in a randomized controlled trial in Sarlahi, Nepal
Q36957563Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States
Q36633673Association between Psychological Flexibility and Health Beliefs in the Uptake of Influenza Vaccination among People with Chronic Respiratory Diseases in Hong Kong
Q34106198Association between antibody titers and protection against influenza virus infection within households
Q38950526Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States.
Q50065275Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness
Q47678684Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons
Q92915035Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort
Q47548718Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis
Q36141965Classification and Regression Tree (CART) analysis to predict influenza in primary care patients
Q39242282Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination
Q90621783Comparison of human H3N2 antibody responses elicited by egg-based, cell-based, and recombinant protein-based influenza vaccines during the 2017-2018 season
Q42145296Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness
Q38614227Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old
Q47692575Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults
Q40713908Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly
Q64124882Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study
Q30373099Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.
Q30383252Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.
Q34770845Detection of influenza virus infection using two PCR methods
Q39215322Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera
Q50044242Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine
Q35589650Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012-2013 Season in the United States
Q53283393Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.
Q54513872Editorial Commentary: Influenza Vaccine Effectiveness: A Glass Both Half Full and Half Empty.
Q64130248Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016
Q36783231Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults
Q30401497Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus
Q30391150Effect of Statin Use on Influenza Vaccine Effectiveness
Q30403059Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain
Q41109359Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States
Q38378102Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season
Q34451202Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies
Q40107978Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates
Q40015287Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
Q92942088Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019
Q98578103Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine
Q37568436Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.
Q51660857Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness.
Q40094268Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
Q38587366Efficacy and effectiveness of live attenuated influenza vaccine in school-age children
Q40670577Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.
Q52627557Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines.
Q41694953Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season
Q30400623Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States
Q58722425Estimating Vaccine-Driven Selection in Seasonal Influenza
Q92499114Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017
Q64130596Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population
Q59351771Evaluation of the field-protective effectiveness of seasonal influenza vaccine among Korean children aged < 5 years during the 2014-2015 and 2015-2016 influenza seasons: a cohort study
Q52805071Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically-attended influenza: results of the European I-MOVE multicentre test-negative case-control study, 2011/12-2016/17.
Q39375320Factors affecting immune responses to the influenza vaccine
Q37159633Factors associated with maternal influenza immunization decision-making. Evidence of immunization history and message framing effects
Q40140855Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes
Q34974842Frequency of acute respiratory illnesses and circulation of respiratory viruses in households with children over 3 surveillance seasons
Q64276594HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
Q52845428Hintergrundpapier der STIKO: Evaluation der bestehenden Influenzaimpfempfehlung für Indikationsgruppen und für Senioren (Standardimpfung ab 60 Jahren).
Q38408953Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14.
Q42592060How can we solve the enigma of influenza vaccine-induced protection?
Q40734674Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio
Q36497877Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013
Q59349308Immune History and Influenza Vaccine Effectiveness
Q39088963Immune history and influenza virus susceptibility
Q37560954Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
Q36705828Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness
Q64136777Impact of repeated influenza vaccinations in persons over 65 years of age: A large population-based cohort study of severe influenza over six consecutive seasons, 2011/12-2016/17
Q34393525Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons
Q47564122Impact of seasonal influenza vaccination in the presence of vaccine interference
Q52315590Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications on Seasonal Vaccine Strain Selection and Vaccine Performance.
Q41053454Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons
Q41201663Increasing herd immunity with influenza revaccination
Q30391418Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination
Q47549841Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States
Q42242172Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine
Q30397977Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement
Q44292787Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?
Q30383312Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
Q38406947Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015.
Q38756456Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014.
Q58110187Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017
Q37568360Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses
Q36446113Influenza Vaccine Effectiveness in a Low-Income, Urban Community Cohort
Q40089214Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season
Q59352861Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season
Q90041536Influenza Vaccine Intention After a Medically Attended Acute Respiratory Infection
Q90678295Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season
Q33776771Influenza vaccination and treatment in children with neurologic disorders
Q40261504Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers
Q47137946Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada
Q38417597Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
Q40068128Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season
Q42201843Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China
Q36783905Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings
Q42187912Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012.
Q40191494Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014
Q39833076Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid epidemiological and virological assessment
Q86127719Influenza vaccine effectiveness in elderly people
Q35715694Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility
Q54277492Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
Q38408870Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15.
Q34505958Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain
Q57530834Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015
Q58124629Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010/11 to 2015/16
Q35531934Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type
Q89041842Influenza vaccine failure: failure to protect or failure to understand?
Q47889238Influenza vaccine response: future perspectives
Q94601233Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China
Q36358260Intention to receive influenza vaccine after an acute respiratory illness
Q38957414Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017.
Q30359268Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014.
Q42237299Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.
Q41474318Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.
Q64126022Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment
Q41510419Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015-2016: A Systematic Review and Meta-Analysis
Q47386997Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community
Q35667123Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice
Q35705382Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015
Q39837983Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season
Q91801945Modular epitope binding predicts influenza quasispecies dominance and vaccine effectiveness: Application to 2018/19 season
Q40280573Moving Toward Improved Influenza Vaccines
Q88632441Multimorbidity is associated with uptake of influenza vaccination
Q39422605Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan
Q57093953Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity
Q47709222On the bias of estimates of influenza vaccine effectiveness from test-negative studies
Q64132510Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons
Q36306922Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination
Q41930762Perspectives from the society for pediatric research (SPR): Decreased effectiveness of the live attenuated influenza vaccine (LAIV).
Q47605953Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission.
Q39813068Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.
Q34778408Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review
Q64134459Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)
Q40152643Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States
Q38995372Protection of children against influenza: Emerging problems
Q97530377Quantifying the annual incidence and underestimation of seasonal influenza: A modelling approach
Q36403075Quantifying the economic value and quality of life impact of earlier influenza vaccination
Q59357833Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women
Q98497953Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19
Q92214805Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
Q40280348Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza
Q39340731Repeated annual influenza vaccination and vaccine effectiveness: review of evidence
Q49400944Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study.
Q91941703Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets
Q47814632Reply to: Estimating the Full Value of High-Dose Influenza Vaccine
Q35557380Results of a pilot study using self-collected mid-turbinate nasal swabs for detection of influenza virus infection among pregnant women
Q30360610Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals.
Q33619841School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015.
Q36518793Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine
Q40146222Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.
Q30383722Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach
Q92686229Serious outcomes of medically attended, laboratory-confirmed influenza illness among school-aged children with and without asthma, 2007-2018
Q35997473Socioeconomic Disparities and Influenza Hospitalizations, Tennessee, USA.
Q35225209Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult Korean populations
Q30381731Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated
Q40248207The Doctrine of Original Antigenic Sin: Separating Good From Evil
Q47700569The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia
Q41919202The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine
Q90692852The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology
Q100528502The challenges of vaccine strain selection
Q36131193The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines
Q34194443The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013.
Q92084109The effectiveness of influenza vaccination in preventing hospitalizations in elderly in Beijing, 2016-18
Q36207731The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012
Q38639994The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis
Q60912426The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis
Q92640448The impact of repeated vaccination using 10-year vaccination history on protection against influenza in older adults: a test-negative design study across the 2010/11 to 2015/16 influenza seasons in Ontario, Canada
Q47287114The impact of selection bias on vaccine effectiveness estimates from test-negative studies
Q34354261Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season
Q26796300Vaccination of healthcare workers: A review
Q39961932Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Q36385284Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease
Q38803189Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

Search more.